莫西沙星

CAS号
186826-86-8 ;151096-09-2
CCD编号
CCD00180752
分子式
C21 H24 F N3 O4 . Cl H
分子量
437.897

基本信息

产品名称: 莫西沙星
CAS: 186826-86-8 ;151096-09-2
中文同义词: 盐酸莫西沙星 ; 莫西沙星
英文同义词: 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-[(4AS,7AS)-OCTAHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL]-4-OXO-1,4-DIHYDRO-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE ; AVELOX ; MOXIFLOXACIN (HYDROCHLORIDE) ; OCTEGRA ; 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-[(4AS,7AS)-OCTAHYDRO-6H-PYRROLO[3,4-B]PYRIDIN-6-YL]-4-OXO-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE ; 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-[(4AS,7AS)-OCTAHYDROPYRROLO[3,4-B]PYRIDIN-6-YL]-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE ; PROFLOX ; 1-CYCLOPROPYL-7-[(S,S)-2,8-DIAZA-BICYCLO[4.3.0]NON-8-YL]-6-FLUORO-8-METHOXY-1,4-DIHYDRO-4-OXO-3-QUINOLINE CARBOXYLIC ACID HYDROCHLORIDE ; (1'S,6'S)-1-CYCLOPROPYL-7-(2,8-DIAZABICYCLO[4.3.0]NON-8-YL)-6-FLUORO-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE ; ACTURA ; MOXIFLOXACIN HCL ; MOXIFLOXACIN ; 1-CYCLOPROPYL-6-FLUORO-7-((4AS,7AS)-HEXAHYDRO-1H-PYRROLO[3,4-B]PYRIDIN-6(2H)-YL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE ; 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-4-OXO-7-((4AS,7AS)-TETRAHYDRO-1H-PYRROLO[3,4-B]PYRIDIN-6(2H,7H,7AH)-YL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID HYDROCHLORIDE ; AVALOX ; MOXIFLOXACIN HYDROCHLORIDE ; MOXIFLOXACINE HYDROCHLORIDE
MDL号: MFCD00949117
氢键受体数量: 7
氢键供体数量: 2
Smile: COc1c2c(cc(c1N3C[C@@H]4CCCN[C@@H]4C3)F)c(=O)c(cn2C5CC5)C(=O)O.Cl
InChi: InChI=1S/C21H24FN3O4.ClH/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24;/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28);1H/t11-,16+;/m0./s1
InChiKey: InChIKey=IDIIJJHBXUESQI-DFIJPDEKSA-N

性质

注解: GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

安全信息

* If the product has intellectual property rights, a license granted is must or contact us.